However, the tumor volume of pCMV6-H19/Dox group was smaller than that of pCMV6/Dox group, and significant difference in the tumor volume was observed between the two group (Figure 5(b)), suggesting that enforced H19 was resistant to Dox breast cancer cells in vivo. This evidence concerns the gene H19 and breast carcinoma.